Janus Henderson Investors US’s Phibro Animal Health PAHC Stock Holding History

Janus Henderson Investors US’s Portfolio PAHC Stock Details PAHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$6.98M	Sell	248,318 -54,855	-18%	-$1.55M	0.01%	758
2016 Q4	$8.88M	Sell	303,173 -20,433	-6%	-$558K	0.01%	736
2016 Q3	$8.8M	Buy	323,606 +31,163	+11%	+$705K	0.01%	715
2016 Q2	$5.46M	Buy	292,443 +35,910	+14%	+$749K	﹤0.01%	763
2016 Q1	$6.94M	Sell	256,533 -56,748	-18%	-$1.63M	0.01%	721
2015 Q4	$9.44M	Sell	313,281 -387	-0.1%	-$12.4K	0.01%	717
2015 Q3	$9.92M	Buy	313,668 +9,408	+3%	+$344K	0.01%	718
2015 Q2	$11.8M	Sell	304,260 -31,973	-10%	-$1.1M	0.01%	684
2015 Q1	$11.9M	Buy	336,233 +5,841	+2%	+$188K	0.01%	688
2014 Q4	$10.4M	Sell	330,392 -34,911	-10%	-$966K	0.01%	692
2014 Q3	$8.19M	Sell	365,303 -101,654	-22%	-$2.04M	0.01%	716
2014 Q2	$10.3M	Buy	+466,957	New	+$8.88M	0.01%	683

Other funds holding PAHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

FIM

Foresters Investment Management New York $5.05B AUM 5.06% 1-Year Est. Return

VFA

Virtus Fund Advisers Hartford, Connecticut $32.1M AUM 39.5% 1-Year Est. Return

TIM

Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DIA

Denver Investment Advisors Denver, Colorado $1.89B AUM 7.9% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Janus Henderson Investors US's PAHC Position: Q1 2017 in Review

Janus Henderson Investors US reduced its Phibro Animal Health (PAHC) stake by 18% in Q1 2017, selling an estimated $1.55M and leaving 248,318 shares worth $6.98M. The position accounts for 0.01% of the portfolio, ranked #758.

Janus Henderson Investors US first reported a position in PAHC in Q2 2014 and has held it in 12 quarters since. The position peaked at $11.9M in Q1 2015. 155 funds tracked by Wall St. Rank hold PAHC as of Q1 2017.

Janus Henderson Investors US held 248,318 shares of Phibro Animal Health worth $6.98M as of Q1 2017.
Janus Henderson Investors US sold 54,855 Phibro Animal Health shares in Q1 2017, an estimated $1.55M.
Phibro Animal Health made up 0.01% of Janus Henderson Investors US's portfolio in Q1 2017, its #758 holding.
Janus Henderson Investors US first reported a position in Phibro Animal Health in Q2 2014 and has held it in 12 quarters since.
Janus Henderson Investors US's Phibro Animal Health position peaked at $11.9M in Q1 2015.
155 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2017.

Based on Janus Henderson Investors US's 13F filing for Q1 2017, filed 16 May 2017.